Q4 24: Finally, firing on all cylinders?
31/01/25 -"Getinge reported strong Q4 24 results, exceeding consensus expectations. Benefiting from a recovery in acute care and life sciences, revenue increased by 9.2%. Effective cost management led to a 63% ..."
Pages
59
Language
English
Published on
31/01/25
You may also be interested by these reports :
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...
05/02/26
GN’s Q4 results fell short of market expectations. While Hearing experienced healthy growth, this was overshadowed by weaknesses in Gaming and ...
05/02/26
Our estimates have been moderated following the Q4 25 miss, primarily reflecting a softer order book and growth momentum (especially for the LS ...